litlas
Log inCreate account

Marc Lipsitch

Active 1991–2025

256
Papers
57,361
Citations
128
h-index
247
i10-index

Citations

Citations per year for Marc Lipsitch1916: 1 citations1922: 1 citations1961: 1 citations1977: 1 citations1981: 1 citations1982: 1 citations1986: 1 citations1987: 1 citations1989: 1 citations1990: 2 citations1992: 3 citations1993: 2 citations1994: 3 citations1995: 5 citations1996: 14 citations1997: 15 citations1998: 20 citations1999: 60 citations2000: 69 citations2001: 80 citations2002: 94 citations2003: 122 citations2004: 167 citations2005: 178 citations2006: 203 citations2007: 247 citations2008: 236 citations2009: 274 citations2010: 301 citations2011: 343 citations2012: 359 citations2013: 404 citations2014: 360 citations2015: 375 citations2016: 304 citations2017: 428 citations2018: 346 citations2019: 984 citations2020: 3,332 citations2021: 3,581 citations2022: 2,857 citations2023: 1,230 citations2024: 1,321 citations2025: 588 citations2026: 36 citations1917–1921: no citations, so these years are not shown1923–1960: no citations, so these years are not shown1962–1976: no citations, so these years are not shown1978–1980: no citations, so these years are not shown1983–1985: no citations, so these years are not shown1988: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,335 citing papers, 24.1% of this breakdownUnited Kingdom: 2,719 citing papers, 10.3% of this breakdownChina: 1,599 citing papers, 6.1% of this breakdownCanada: 938 citing papers, 3.6% of this breakdownFrance: 893 citing papers, 3.4% of this breakdownGermany: 838 citing papers, 3.2% of this breakdownItaly: 820 citing papers, 3.1% of this breakdownAustralia: 791 citing papers, 3% of this breakdownSwitzerland: 640 citing papers, 2.4% of this breakdownSpain: 622 citing papers, 2.4% of this breakdownNetherlands: 588 citing papers, 2.2% of this breakdownIndia: 581 citing papers, 2.2% of this breakdown
0%24.1%Other 34%

Institutions

Fields

  • Medicine53.3%
  • Mathematics15.3%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Immunology and Microbiology6%
  • Social Sciences2.8%
  • Environmental Science2.7%
  • Other9.1%

Topics

  • SARS-CoV-2 and COVID-19 Research9.3%
  • COVID-19 epidemiological studies8.6%
  • COVID-19 Clinical Research Studies5.1%
  • Influenza Virus Research Studies3.2%
  • Vaccine Coverage and Hesitancy2.8%
  • Pneumonia and Respiratory Infections2.7%
  • Other68.3%

Coauthors

All papers

Open in search
  1. Negative Controls

    Authors: Marc Lipsitch, Eric Tchetgen Tchetgen, Ted Cohen - Epidemiology 2010 cited by 1,484

  2. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

    Authors: Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A. Katz, Miguel A. Hernán, Marc Lipsitch, Ben Y. Reis, Ran D. Balicer - New England Journal of Medicine 2021 cited by 2,810

  3. Practical considerations for measuring the effective reproductive number, Rt

    Authors: Katelyn M. Gostic, Lauren McGough, Edward B. Baskerville, Sam Abbott, Keya Joshi, Christine Tedijanto, Rebecca Kahn, Rene Niehus, James A. Hay, Pablo M. De Salazar, Joel Hellewell, Sophie Meakin, James D. Munday, Nikos I. Bosse, Katharine Sherratt, Robin N. Thompson, Laura F. White, Jana S. Huisman, Jérémie Scire, Sebastian Bonhoeffer, Tanja Stadler, Jacco Wallinga, Sebastian Funk, Marc Lipsitch, Sarah Cobey - PLoS Computational Biology, PLoS Comput. Biol. 2020 cited by 632

  4. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

    Authors: Stephen M. Kissler, Christine Tedijanto, Edward Goldstein, Yonatan H. Grad, Marc Lipsitch - Science 2020 cited by 2,819

  5. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

    Authors: Noam Barda, Noa Dagan, Yatir Ben‐Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A. Hernán, Marc Lipsitch, Isaac S. Kohane, Doron Netzer, Ben Y. Reis, Ran D. Balicer - New England Journal of Medicine 2021 cited by 1,052

  6. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

    Authors: Sarah E. Daugherty, Yinglong Guo, Kevin Heath, Micah C Dasmariñas, Karol Giuseppe Jubilo, Jirapat Samranvedhya, Marc Lipsitch, Ken Cohen - BMJ 2021 cited by 449

  7. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

    Authors: Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, E G Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta S. Zuckerman, Adina Bar‐Chaim, Yitshak Kreiss, Gili Regev‐Yochay - New England Journal of Medicine 2021 cited by 1,486

  8. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

    Authors: Kate M. Bubar, Kyle Reinholt, Stephen M. Kissler, Marc Lipsitch, Sarah Cobey, Yonatan H. Grad, Daniel B. Larremore - Science 2021 cited by 855

  9. How generation intervals shape the relationship between growth rates and reproductive numbers

    Authors: Jacco Wallinga, Marc Lipsitch - Royal Society B Biological Sciences, Proceedings of the Royal Society B Biological Sciences 2006 cited by 1,402

  10. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

    Authors: Noam Barda, Noa Dagan, Cyrille J. Cohen, Miguel A. Hernán, Marc Lipsitch, Isaac S. Kohane, Ben Y. Reis, Ran D. Balicer - The Lancet 2021 cited by 941

  11. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study

    Authors: Ken Cohen, Sheng Ren, Kevin Heath, Micah C Dasmariñas, Karol Giuseppe Jubilo, Yinglong Guo, Marc Lipsitch, Sarah E. Daugherty - BMJ 2022 cited by 236

  12. Antibiotics in agriculture and the risk to human health: how worried should we be?

    Authors: Qiuzhi Chang, Weike Wang, Gili Regev‐Yochay, Marc Lipsitch, William P. Hanage - Evolutionary Applications 2014 cited by 562

  13. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

    Authors: Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, Yaniv Lustig, Ran D. Balicer - Nature reviews. Immunology 2021 cited by 355

  14. Serotype replacement in disease after pneumococcal vaccination

    Authors: Daniel M. Weinberger, Richard Malley, Marc Lipsitch - The Lancet 2011 cited by 1,038

  15. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

    Authors: Joseph A. Lewnard, Vennis Hong, Manish M. Patel, Rebecca Kahn, Marc Lipsitch, Sara Y. Tartof - Nature Medicine 2022 cited by 365

  16. Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in Pregnancy

    Authors: Ran D. Balicer, Noa Dagan, Noam Barda, Tal Biron‐Shental, Maya Makov-Assif, Calanit Key, Isaac S. Kohane, Miguel A. Hernán, Marc Lipsitch, Sonia Hernández–Dı́az, Ben Y. Reis - Nature Medicine 2021 cited by 311

  17. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution

    Authors: Thuy Doan, Lee Worden, Armin Hinterwirth, Ahmed M. Arzika, Ramatou Maliki, Amza Abdou, Lina Zhong, Cindi Chen, Catherine Cook, Elodie Lebas, Kieran S. O’Brien, Catherine E. Oldenburg, Eric D. Chow, Travis C. Porco, Marc Lipsitch, Jeremy D. Keenan, Thomas M. Lietman - New England Journal of Medicine 2020 cited by 183

  18. Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework

    Authors: Johan Vekemans, Mateusz Hasso-Agopsowicz, Gagandeep Kang, William P. Hausdorff, Anthony E. Fiore, Elizabeth Tayler, Elizabeth J. Klemm, Ramanan Laxminarayan, Padmini Srikantiah, Martin Friede, Marc Lipsitch - Clinical Infectious Diseases 2021 cited by 127

  19. Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora

    Authors: Christine Tedijanto, Scott W. Olesen, Yonatan H. Grad, Marc Lipsitch - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 211

  20. The Use of Test-negative Controls to Monitor Vaccine Effectiveness

    Authors: Huiying Chua, Shuo Feng, Joseph A. Lewnard, Sheena G. Sullivan, Christopher C. Blyth, Marc Lipsitch, Benjamin J. Cowling - Epidemiology 2019 cited by 182

  21. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

    Authors: Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, René Niehus, Pablo M. De Salazar, Benjamin J. Cowling, Marc Lipsitch, GM Leung - Nature Medicine 2020 cited by 1,404

  22. The distribution of antibiotic use and its association with antibiotic resistance

    Authors: Scott W. Olesen, Michael L. Barnett, Derek R. MacFadden, John S. Brownstein, Sonia Hernández–Dı́az, Marc Lipsitch, Yonatan H. Grad - eLife 2018 cited by 217

  23. Aggregated mobility data could help fight COVID-19

    Authors: Caroline O. Buckee, Satchit Balsari, Jennifer Chan, Mercè Crosas, Francesca Dominici, Urs Gasser, Yonatan H. Grad, Bryan T. Grenfell, M. Elizabeth Halloran, Moritz U. G. Kraemer, Marc Lipsitch, C. Jessica E. Metcalf, Lauren Ancel Meyers, T. Alex Perkins, Mauricio Santillana, Samuel V. Scarpino, Cécile Viboud, Amy Wesolowski, Andrew Schroeder - Science 2020 cited by 464

  24. Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

    Authors: Ori Magen, Jacob G. Waxman, Maya Makov-Assif, Roni Vered, Dror Dicker, Miguel A. Hernán, Marc Lipsitch, Ben Y. Reis, Ran D. Balicer, Noa Dagan - New England Journal of Medicine 2022 cited by 283